Paper40298389
Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies.
Koh K and 8 others. Cancer Discov, 2025. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies. Papers, record 40298389. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40298389
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cancer-Associated Cachexia: Bridging Clinical Findings with Mechanistic Insights in Human Studies.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cachexia | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Quality of Life | |
| Animals |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| OT2 CA278690 | NCI NIH HHS | United States | OT2CA278690 | PubMed and NIH | NIH RePORTER |
| OT2 CA278701 | NCI NIH HHS | United States | OT2CA278701 | PubMed and NIH | NIH RePORTER |
| P30 CA045508 | NCI NIH HHS | United States | P30CA045508 | PubMed | NIH RePORTER |
References314
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20013699 | [Leptin serum levels in cachectic and non-cachectic lung cancer patients]. | Pneumonol Alergol Pol | 2009 | https://conductscience.org/library/papers/20013699 | PubMed |
| 2 | 28094194 | MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study. | Lancet Oncol | 2017 | https://conductscience.org/library/papers/28094194 | PubMed |
| 3 | 38738581 | Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series. | J Cachexia Sarcopenia Muscle | 2024 | https://conductscience.org/library/papers/38738581 | PubMed |
| 4 | 37046095 | The evolution of non-small cell lung cancer metastases in TRACERx. | Nature | 2023 | https://conductscience.org/library/papers/37046095 | PubMed |
| 5 | 2582730 | Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer. | Clin Physiol | 1989 | https://conductscience.org/library/papers/2582730 | PubMed |
| 6 | 16186396 | Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. | Diabetes | 2005 | https://conductscience.org/library/papers/16186396 | PubMed |
| 7 | 19647909 | Resting energy expenditure and body composition in patients with newly detected cancer. | Clin Nutr | 2010 | https://conductscience.org/library/papers/19647909 | PubMed |
| 8 | 4828442 | Lactate inhibition of lipolysis in exercising man. | Metabolism | 1974 | https://conductscience.org/library/papers/4828442 | PubMed |
| 9 | 33137293 | Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials. | Lancet Diabetes Endocrinol | 2020 | https://conductscience.org/library/papers/33137293 | PubMed |
| 10 | 25043053 | Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. | Nature | 2014 | https://conductscience.org/library/papers/25043053 | PubMed |
| 11 | 31390573 | Modeling Human Cancer-induced Cachexia. | Cell Rep | 2019 | https://conductscience.org/library/papers/31390573 | PubMed |
| 12 | 27030813 | Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients. | J Cachexia Sarcopenia Muscle | 2016 | https://conductscience.org/library/papers/27030813 | PubMed |
| 13 | 9392477 | Tumor necrosis factor-alpha induces apoptosis of human adipose cells. | Diabetes | 1997 | https://conductscience.org/library/papers/9392477 | PubMed |
| 14 | 26903572 | Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer. | J Clin Oncol | 2016 | https://conductscience.org/library/papers/26903572 | PubMed |
| 15 | 27829137 | Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity. | Cell Metab | 2016 | https://conductscience.org/library/papers/27829137 | PubMed |
| 16 | 34187898 | Activation of the hypothalamic-pituitary-adrenal axis by exogenous and endogenous GDF15. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34187898 | PubMed |
| 17 | 36860137 | Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia. | J Cachexia Sarcopenia Muscle | 2023 | https://conductscience.org/library/papers/36860137 | PubMed |
| 18 | 25560696 | Network of hypothalamic neurons that control appetite. | BMB Rep | 2015 | https://conductscience.org/library/papers/25560696 | PubMed |
| 19 | 39510253 | Are Lean Body Mass and Fat-Free Mass the Same or Different Body Components? A Critical Perspective. | Adv Nutr | 2024 | https://conductscience.org/library/papers/39510253 | PubMed |
| 20 | 31999069 | Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer. | J Cachexia Sarcopenia Muscle | 2020 | https://conductscience.org/library/papers/31999069 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42926650 | Behavioral dysfunction but not wasting in cancer cachexia is driven by altered tryptophan metabolism. | bioRxiv | 2026 | https://conductscience.org/library/papers/42926650 | PubMed |
| 42869996 | Characterizing the onset and progression of cancer cachexia using routine clinical data. | Nat Med | 2026 | https://conductscience.org/library/papers/42869996 | PubMed |
| 42864412 | A health-system-scale, episode-resolved multimodal atlas of cancer cachexia. | Nat Med | 2026 | https://conductscience.org/library/papers/42864412 | PubMed |
| 42823780 | Metastatic Bone Disease Is Associated With Longitudinal Muscle Loss and Reduced Survival in Kidney Cancer. | J Cachexia Sarcopenia Muscle | 2026 | https://conductscience.org/library/papers/42823780 | PubMed |
| 42778549 | Heterogeneity in cancer: molecular mechanisms and therapeutic strategies. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42778549 | PubMed |
| 42774252 | Risk factors for drug-related cachexia: an analysis based on the FDA adverse event reporting system (FAERS) from 2004 to 2025. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42774252 | PubMed |
| 42711451 | Reflecting on 25 years of cancer research: transformative advances and unmet expectations. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42711451 | PubMed |
| 42563007 | Pre-therapeutic prediction of cachexia in lymphoma patients using [18F]FDG PET radiomics of muscle and fat. | Eur J Clin Nutr | 2026 | https://conductscience.org/library/papers/42563007 | PubMed |
| 42508405 | Therapeutic Gfral silencing via antisense oligonucleotides ameliorates cancer-associated cachexia and extends survival in tumor-bearing mice. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42508405 | PubMed |
| 42417089 | Cancer cachexia: a caregiver and advocate perspective. | Curr Opin Support Palliat Care | 2026 | https://conductscience.org/library/papers/42417089 | PubMed |
| 42231158 | Microbiome and metabolome patterns centered on cancer cachexia link skeletal muscle and adipose tissue depletion to clinical outcomes in locally advanced rectal cancer. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42231158 | PubMed |
| 42117587 | Dietary supplementation with ursolic acid preserves skeletal muscle mass and strength in mouse models of cancer cachexia. | Am J Physiol Cell Physiol | 2026 | https://conductscience.org/library/papers/42117587 | PubMed |
| 41816244 | The pectoralis major index: a novel computed tomography biomarker for low thoracic muscle mass and eastern cooperative oncology group performance status in lung cancer patients. | Front Nutr | 2026 | https://conductscience.org/library/papers/41816244 | PubMed |
| 41749907 | Circulating Inflammatory and Mitochondrial Biomarkers Associated with Cachexia in Advanced Non-Small Cell Lung Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41749907 | PubMed |
| 41681974 | Sarcopenia in Older Adults with Hematologic Malignancies: A Comprehensive Review of Epidemiology, Prognosis, and Interventions. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681974 | PubMed |
| 41313474 | Treatment barriers among patients with cancer cachexia. | Support Care Cancer | 2025 | https://conductscience.org/library/papers/41313474 | PubMed |
| 41219223 | Reframing cancer cachexia: the vagal brain-liver axis as a novel neuro-metabolic target. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41219223 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40298389
GET https://conductscience.org/api/papers/v1/40298389/references?page=2